Search

Your search keyword '"van Baarle, Debbie"' showing total 802 results

Search Constraints

Start Over You searched for: Author "van Baarle, Debbie" Remove constraint Author: "van Baarle, Debbie"
802 results on '"van Baarle, Debbie"'

Search Results

2. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

5. Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney transplant recipients

12. Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses

14. The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients

15. Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial

16. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

17. Ageing Mucosal Immunity and Its Consequences for Infectious Diseases in the Aged; A First Glance

18. Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination

21. mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy.

23. mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial

26. The Memory-CD8+-T-Cell Response to Conserved Influenza Virus Epitopes in Mice Is Not Influenced by Time Since Previous Infection

27. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

28. SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

30. Multiple vaccine comparison in the same adults from the VITAL study reveals vaccine-specific and age-related humoral response patterns.

31. Humoral and cellular immune responses after COVID-19 vaccination of lung transplant recipients and patients on the waiting list: a 6-month follow-up

32. Profiling the Faecal Microbiome and its Modulators Across the Lifespan in the Netherlands

35. The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

38. The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients

41. A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452

43. Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions

47. Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis

Catalog

Books, media, physical & digital resources